Heyuan Biotechnology (Shanghai) Co., Ltd
Initial public offering and listing on the science and Innovation Board
Issuance announcement
Sponsor (lead underwriter): Haitong Securities Company Limited(600837)
Co lead underwriter: Guotai Junan Securities Co.Ltd(601211)
Scan QR code to view the full text of the announcement
Important tips
Heyuan Biotechnology (Shanghai) Co., Ltd. (hereinafter referred to as "Heyuan biotechnology", "issuer" or "company") in accordance with the implementation opinions on establishing a science and innovation board and pilot registration system in Shanghai Stock Exchange (CSRC announcement [2019] No. 2) issued by China Securities Regulatory Commission (hereinafter referred to as "CSRC" and "CSRC") Measures for the administration of securities issuance and underwriting (CSRC order [No. 144]) (hereinafter referred to as the "administrative measures"), measures for the administration of the registration of initial public offering of shares on the science and Innovation Board (for Trial Implementation) (CSRC order [No. 174]), The measures for the implementation of the issuance and underwriting of shares on the science and Innovation Board of Shanghai Stock Exchange (SZF [2021] No. 76) (hereinafter referred to as the "implementation measures") promulgated by the Shanghai Stock Exchange (hereinafter referred to as the "Shanghai Stock Exchange") Guidelines for the application of the issuance and underwriting rules of the science and Innovation Board of Shanghai Stock Exchange No. 1 - initial public offering of shares (SZF [2021] No. 77) (hereinafter referred to as the "underwriting guidelines"), detailed rules for the implementation of online issuance of initial public offering shares in Shanghai market (SZF [2018] No. 40) (hereinafter referred to as the "detailed rules for the implementation of online issuance") Detailed rules for the implementation of offline issuance of initial public offerings in Shanghai market (SZF [2018] No. 41) (hereinafter referred to as "detailed rules for the implementation of offline issuance"), the code for underwriting initial public offerings under the registration system issued by the China Securities Association (zsxf [2021] No. 213) Relevant provisions such as the detailed rules for the administration of offline investors in initial public offering (zxsf [2018] No. 142), the rules for the administration of offline investors in initial public offering under the registration system (zxsf [2021] No. 212), as well as the relevant provisions of the Shanghai Stock Exchange, such as the rules for the issuance and listing of shares and the latest operation guidelines, issued shares for initial public offering and listed on the science and innovation board.
Haitong Securities Company Limited(600837) (hereinafter referred to as " Haitong Securities Company Limited(600837) " or "sponsor (lead underwriter)") serves as the sponsor (lead underwriter) of this offering, and Guotai Junan Securities Co.Ltd(601211) (hereinafter referred to as " Guotai Junan Securities Co.Ltd(601211) ") serves as the joint lead underwriter of this offering ( Haitong Securities Company Limited(600837) and Guotai Junan Securities Co.Ltd(601211) collectively referred to as "joint lead underwriters").
This offering is conducted by a combination of directional placement to strategic investors (hereinafter referred to as "strategic placement"), offline inquiry placement to qualified investors (hereinafter referred to as "offline issuance"), and online pricing issuance to social public investors holding non restricted A-share shares and non restricted depositary receipts market value in Shanghai market (hereinafter referred to as "online issuance"). The strategic placement, preliminary inquiry and online and offline issuance of this offering shall be organized and implemented by the sponsor (lead underwriter). The strategic placement of this offering is carried out at the sponsor (lead underwriter). The preliminary inquiry and offline subscription are carried out through the IPO offline subscription electronic platform of Shanghai Stock Exchange (hereinafter referred to as "offline subscription platform"), and the online issuance is carried out through the trading system of Shanghai Stock Exchange. Please read this announcement carefully. Please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) for details of preliminary inquiry and electronic offline issuance The detailed rules for the implementation of offline issuance and other relevant provisions.
Investors can visit the following website（ http://www.sse.com.cn./disclosure/listedinfo/listing/ 、 http://www.sse.com.cn./ipo/home/ ）Check the full text of the announcement.
Basic information of the issuer
Full name of the company Heyuan Biotechnology (Shanghai) securities abbreviation Heyuan Biotechnology
limited company
Securities code / offline subscription 688238 online subscription code 787238
code
Offline subscription abbreviation and online subscription abbreviation of metabiology
Basic information of this offering
Offline preliminary inquiry directly confirmed
The pricing method determines the issue price, and the number of shares issued this time (10000 shares) is not available offline
Then conduct cumulative bid inquiry
After the issuance, the total share capital (10000 shares) is 493189000, accounting for 20.28% of the issuance
Proportion of total share capital after (%)
High price rejection ratio (%) 1.0071, whichever is lower (yuan / share) 132398
The issue price (yuan) / whether the issue price exceeds
13.23 whichever is lower, and no
Excess range (%)
P / E ratio of issuance (earnings per share in 2020)
Other non recurring valuation indicators deducted from the audit (if applicable)
Attribution before and after profit and loss, whichever is lower (244.67) is not applicable
(calculated by dividing the net profit of shareholders of the parent company by the total share capital after the issuance)
Industry name and industry research and experimental development (branch industry T-3 day static 71.72)
Code category (code "M73") Industry P / E ratio
Determined according to the issue price
Committed to subscribe for a total of 27315019 strategic placements committed to subscribe for a total of 27.32 strategic placements
Proportion of (10000 shares) in the number of shares issued this time
（%）
58684981 offline after strategic placement and 14000000 online after strategic placement
Number of shares issued (10000 shares)
Quantity of each proposed offline subscription
Upper limit (10000 shares) (2800 shares) (100 shares to be subscribed for each offline purchase)
The number should be 100000 shares (10000 shares)
(several times) the number of each proposed online purchase
Upper limit (10000 shares) (subscription of 14000 new shares) placement brokerage fee of 0.5
The number should be 500 shares, integer rate (%)
(Times) calculated according to the issuing price
The estimated total amount of raised funds is 13230000, and the balance of underwriting method is underwriting
Amount (10000 yuan)
Important date of this issuance
Offline Subscription Date and start and end time March 11, 2022 online subscription date and start and end time March 11, 2022 between 9:30-15:00 and 9:30-11:30
13:00-15:00
Offline payment date and deadline March 15, 2022 online payment date and deadline March 15, 2022 end at 16:00
Remarks: 1 "The lower of the four numbers" refers to the lower of the median and weighted average of the remaining quotations of offline investors after excluding the highest quotation, as well as the median and weighted average of the remaining quotations of public offering products, social security funds and pensions.
The issuer and the co lead underwriters solemnly remind investors to pay attention to investment risks and invest rationally. They should carefully read this announcement and publish it in Shanghai Securities News and China Securities News on March 10, 2022 (t-1) Special announcement on investment risk of Heyuan Biotechnology (Shanghai) Co., Ltd. in initial public offering and listing on the science and Innovation Board (hereinafter referred to as "special announcement on investment risk") in the securities times and Securities Daily.
This announcement is only a brief description of the issue of shares and does not constitute investment suggestions. Investors who want to know the details of this offering, please read it carefully and publish it on the website of Shanghai Stock Exchange on March 3, 2022 (www.sse. Com. CN.) Heyuan Biotechnology (Shanghai) Co., Ltd. IPO and listing on the science and Innovation Board (hereinafter referred to as the "prospectus"). The issuer and the co lead underwriters hereby remind investors to pay special attention to the chapters of "tips on major matters" and "risk factors" in the prospectus, fully understand the issuer's risk factors, judge its operation status and investment value by themselves, and make investment decisions prudently. The issuer's operating conditions may change due to the influence of politics, economy, industry and operation and management level, and the possible investment risks arising therefrom shall be borne by the investors themselves.
The listing of the shares will be announced separately. 1、 Preliminary inquiry results and pricing
The application of Heyuan biology for the initial public offering of RMB common shares (A shares) and listing on the science and Innovation Board (hereinafter referred to as "this issuance") has been examined and approved by the stock listing committee of the science and Innovation Board of Shanghai Stock Exchange, and has been approved and registered by the CSRC (zjxk [2022] No. 61). The issuer's stock is referred to as "Heyuan biology" for short, and the expanded stock is referred to as "Heyuan biology" for short. The stock code is "688238". This code is also used for the preliminary inquiry and offline subscription of this issuance. The online subscription code of this issuance is "787238".
The issuance is carried out in a combination of strategic placement, offline issuance and online issuance.
(I) preliminary inquiry
1. Overall declaration
The initial inquiry period of this offering is 9:30-15:00 on March 8, 2022 (T-3). As of 15:00 on March 8, 2022 (T-3), the co lead underwriters have received the preliminary inquiry and quotation information of 10631 placing objects managed by 409 offline investors through the offline subscription platform of Shanghai Stock Exchange. The quotation range is 3.00 yuan / share - 44.40 yuan / share, and the total number of shares to be purchased is 247206 million. For the specific quotation of the placing object, please refer to the "attached table: statistical table of investor quotation information" of this announcement.
2. Investor verification
According to the conditions for offline investors participating in the preliminary inquiry published in the announcement on the issuance arrangement and preliminary inquiry of Heyuan Biotechnology (Shanghai) Co., Ltd. for initial public offering and listing on the science and Innovation Board (hereinafter referred to as the "announcement on issuance arrangement and preliminary inquiry") published on March 3, 2022, after verification by the joint lead underwriters, 37 placing objects managed by 7 offline investors failed to provide review materials or materials as required, but failed to pass the qualification review of joint lead underwriters; 198 placing objects managed by 55 offline investors belong to the scope of prohibited placing; 66 placing objects managed by 4 offline investors failed to submit the pricing basis and suggested price or price range before the inquiry; No placing object intends to purchase more than the asset scale or capital scale in the filing materials submitted by it. The quotations of 301 placing objects managed by the above 66 offline investors have been determined to be invalid and eliminated, and the total number of shares to be purchased is 6775.2 million. For details, see the part marked as "invalid quotation" in the attached table "statistical table of investor quotation information".
After excluding the above invalid quotations, the 10330 placing objects managed by the remaining 403 offline investors all meet the conditions of offline investors specified in the announcement on issuance arrangement and preliminary inquiry. The quotation range is 3.00 yuan / share - 44.40 yuan / share, and the total number of shares to be purchased is 2404308 million.
(II) excluding the highest quotation
1. Elimination
Based on the inquiry results after excluding the above invalid quotation, the issuer and the joint lead underwriters rank the purchase price from high to low, and calculate the cumulative total amount of proposed purchase corresponding to each price. For the same purchase price, from small to large, for the same purchase price, from late to early For the same proposed purchase price, the same proposed purchase quantity and the same purchase time (the purchase time shall be subject to the records of the offline purchase platform of Shanghai Stock Exchange), the placement objects automatically generated by the offline purchase platform of Shanghai Stock Exchange shall be sorted from bottom to top, and the purchase with the highest quotation in the total amount of proposed purchase shall be excluded
